Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome
Abstract Background Polycystic ovary syndrome (PCOS) is a complex condition with high risk for dyslipidemia, dysglycemia, venous thromboembolism, cardiovascular disease and metabolic syndrome. Because the combined oral contraceptive (COC) use has also been associated with impaired fasting glucose, i...
Main Author: | Sebastião Freitas de Medeiros |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | Reproductive Biology and Endocrinology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12958-017-0313-y |
Similar Items
-
Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome
by: Chan-Hong Park, et al.
Published: (2020-01-01) -
Postpartum contraception: efficacy and safety
by: N M Nazarova, et al.
Published: (2018-04-01) -
Postpartum contraception: efficacy and safety
by: N.M.Nazarova, et al.
Published: (2018-03-01) -
Polycystic ovary syndrome hormonal pharmacotherapy
by: С. Б. Чечуга
Published: (2019-04-01) -
An Update on Contraception in Polycystic Ovary Syndrome
by: Seda Hanife Oguz, et al.
Published: (2021-04-01)